- how it works : - Imagine you can create apples, and that you are the only one in the world able to do that. - So if you create 100 apples, you will make them more rare and unique, so maybe you can sell them for 10$ each one. - So now imagine you create 10,000,000,000 apples, you will have more apples than peoples need to eat, so you will have to sell your...
After correctly giving you the Bitcoin and Chainlink bottom, I think it's time to look at some other alt coin opportunities. One project I'm definitely bullish on is Quant Network: $QNT. Very low max supply of around 14M coins, no inflation but above all currently heavily involved in Project Rosalind, a joint experimentation of the Bank of England and The Bank...
With a similar situation emerging to the 2008 financial crisis wherein gold and the stock market along with many other assets depreciated simultaneously, and Coronavirus creating a more risk averse investing atmosphere, The best trade to take now is to wait for a pullback to 1450 (likely entry) or 1400. The long term trend line shows that gold will find support...
The NASDAQ Biotech has just broken the monthly support line with bearish divergence. Bear marketing coming soon?
As soon as the red solid channel breaks. it's time to party. www.zacks.com
It's a buy those who doesn't like to go short IBB www.zacks.com
Biotech stocks had tremendous runs over the last few years. Many advancing several hundred percent. But all good things in the stock market come to end, and the biotech group is no exception. The advance over the last four to five years clearly reflected the improved growth rates that we saw biotech companies deliver over those years, and current fundamentals...
4-22 Could It Be? Is this where we carve out a double bottom? If so then IBB (longside) MAY be carving out a double top. Remember, going long this is gaining short exposure in the bios. BIIB (Biogen) reports so be aware it could have an impact on this issue. Chart wise its all about an upside crossover of the green line. Feel free to follow on TWTR...